NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Fiserv, Inc. (NYSE: FI). Shareholders who purchased shares of FI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/fiserv-inc-loss-submission-form/?id=162529&from=3 CLASS PERIOD: July 24, 2024 to July 22, 2 ...

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sable Offshore Corp. (NYSE: SOC). Shareholders who purchased shares of SOC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/sable-offshore-corp-loss-submission-form/?id=162518&from=3  CLASS PERIOD: This la ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fiserv, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Clover platform and its impact on revenue growth [1][3]. Summary by Relevant Sections Allegations - The complaint alleges that Fiserv misled investors by failing to disclose issues with its older point-of-sale platform, Payeezy, which forced merchants to switch to Clover [3]. - It is claimed that Clover's revenue growth was artificially inflated due to these conversions, masking a slowdown in new merchant acquisitions [3]. - Following the switch, many former Payeezy merchants reportedly moved to competitors due to Clover's high pricing and poor customer service [3]. - As a result, Clover's growth in Gross Payment Volume (GPV) and revenue was said to be unsustainable and significantly slowing [3]. - The lawsuit asserts that Fiserv's positive statements regarding Clover's growth strategies and business prospects were materially false and misleading [3]. Class Action Details - The class period for the lawsuit is defined as July 24, 2024, to July 22, 2025 [3]. - Shareholders are encouraged to register for the class action by September 22, 2025, to potentially be appointed as lead plaintiffs [4]. - Participation in the case does not incur any costs or obligations for shareholders [4]. Firm Background - The Gross Law Firm is recognized nationally for its commitment to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies engage in responsible business practices and seeks recovery for investors affected by misleading statements [5].

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations related to the proposed acquisition of International Money Express, Inc. by The Western Union Company, which is valued at approximately $500 million [1]. Group 1: Acquisition Details - The proposed acquisition will provide stockholders of International Money Express with $16.00 for each share they hold [1]. - The transaction is expected to close in the second half of 2026 [1]. Group 2: Legal Investigation - Rowley Law PLLC is conducting an investigation into the actions of the board of directors of International Money Express concerning the acquisition [1]. - Shareholders interested in more information regarding the investigation can contact Rowley Law PLLC [2].

Core Viewpoint - Altimmune, Inc. faced significant stock price decline following the announcement of disappointing results from its IMPACT Phase 2b MASH trial of Pemvidutide, leading to a class action notice for shareholders [3][4]. Group 1: Company Performance - On June 26, 2025, Altimmune announced topline results from the IMPACT Phase 2b MASH trial, which failed to achieve statistical significance in the primary endpoint of fibrosis reduction [3]. - The stock price of Altimmune dropped from $7.71 per share on June 25, 2025, to $3.61 per share on June 26, 2025, marking a decline of 53.2% in one day [3]. Group 2: Shareholder Actions - Shareholders who purchased shares during the class period from August 10, 2023, to June 25, 2025, are encouraged to contact the Gross Law Firm regarding potential lead plaintiff appointment [3][4]. - The deadline for shareholders to seek lead plaintiff status is October 6, 2025, and there is no cost or obligation to participate in the case [4]. Group 3: Legal Context - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to recover losses incurred by investors due to misleading statements or omissions by companies that artificially inflated stock prices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of XPLR Infrastructure, LP (formerly Nextera Energy Partners, LP), encouraging them to contact the firm regarding potential lead plaintiff appointments in a class action lawsuit due to alleged misleading statements and operational struggles during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from September 27, 2023, to January 27, 2025 [3]. - Allegations include that XPLR was struggling to maintain operations as a yieldco, and that the defendants issued materially false and misleading statements while downplaying risks associated with financing arrangements [3]. - It is claimed that XPLR could not resolve financing issues before maturity without risking significant unitholder dilution, leading to a planned halt in cash distributions to investors [3]. - The sustainability of XPLR's yieldco business model and distribution growth rate is questioned, with assertions that public statements made by the defendants were materially false and misleading [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by September 8, 2025, to participate in the case without any cost or obligation [4]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that artificially inflated stock prices [5].

Core Viewpoint - Berger Montague PC is investigating potential securities law violations involving RxSight, Inc. following a class action lawsuit filed on behalf of investors who acquired RxSight securities during the specified Class Period [1][2]. Company Overview - RxSight, headquartered in Aliso Viejo, CA, is a medical technology company that develops light adjustable intraocular lenses (LAL) used in cataract surgery [2]. Legal Allegations - The lawsuit alleges that RxSight failed to disclose significant issues, including: 1. Adoption challenges and structural issues leading to declines in sales and utilization [3]. 2. Overstated demand for RxSight's products [3]. 3. Unlikelihood of meeting previously issued financial guidance for fiscal year 2025 [3]. Financial Impact - On July 8, 2025, RxSight reported significant declines in LDD sales, LAL utilization, and overall revenue for Q2 2025, subsequently lowering its full-year 2025 revenue guidance. CEO Ronald Kurtz attributed the decline to adoption challenges [4]. - Following this announcement, RxSight shares fell by $4.84, or 37%, closing at $7.95 per share on July 9, 2025 [4].

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (NYSE: XIFR). Shareholders who purchased shares of XIFR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/xplr-infrastructure-lp-f-k-a-nextera-energ ...

Core Viewpoint - Berger Montague PC is investigating potential securities law violations involving RxSight, Inc. following a class action lawsuit filed on behalf of investors who acquired RxSight securities during the specified class period [1][2]. Company Overview - RxSight, Inc. is a medical technology company based in Aliso Viejo, CA, specializing in light adjustable intraocular lenses (LAL) used in cataract surgery, with its system involving the Light Delivery Device (LDD) [2]. Legal Allegations - The lawsuit alleges that RxSight's management failed to disclose significant issues, including: 1. Adoption challenges and structural issues leading to declines in sales and utilization [3]. 2. Overstated demand for RxSight's products [3]. 3. Unlikelihood of meeting previously issued financial guidance for fiscal year 2025 [3]. Financial Impact - On July 8, 2025, RxSight reported significant declines in LDD sales, LAL utilization, and overall revenue for Q2 2025, subsequently lowering its full-year 2025 revenue guidance. CEO Ronald Kurtz attributed the sales stall to adoption challenges over recent quarters [4]. - Following this announcement, RxSight shares fell by $4.84, or 37%, closing at $7.95 per share on July 9, 2025 [4].

NEW YORK, July 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fortrea Holdings Inc. (NASDAQ: FTRE).Shareholders who purchased shares of FTRE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/fortrea-holdings-inc-loss-submission-form/?id=157761&from=4CLASS PERIOD: July 3, 20 ...